Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 1
2006 2
2007 3
2008 1
2010 2
2011 3
2012 2
2013 3
2014 1
2015 1
2016 3
2017 3
2018 4
2019 1
2020 4
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Author's Response.
Kawabata N, Hata A, Aoki T. Kawabata N, et al. Among authors: aoki t. J Pain Symptom Manage. 2020 Aug;60(2):e107-e108. doi: 10.1016/j.jpainsymman.2020.04.011. Epub 2020 Apr 17. J Pain Symptom Manage. 2020. PMID: 32305575 Free article. No abstract available.
Management of glioblastoma.
Aoki T, Hashimoto N, Matsutani M. Aoki T, et al. Expert Opin Pharmacother. 2007 Dec;8(18):3133-46. doi: 10.1517/14656566.8.18.3133. Expert Opin Pharmacother. 2007. PMID: 18035958 Review.
[Temozolomide (TMZ)].
Aoki T. Aoki T. Nihon Rinsho. 2016 Sep;74 Suppl 7:640-645. Nihon Rinsho. 2016. PMID: 30634826 Japanese. No abstract available.
Endovascular embolization of branch-incorporated cerebral aneurysms.
Kawabata Y, Nakazawa T, Fukuda S, Kawarazaki S, Aoki T, Morita T, Tsukahara T. Kawabata Y, et al. Among authors: aoki t. Neuroradiol J. 2017 Dec;30(6):600-606. doi: 10.1177/1971400917698002. Neuroradiol J. 2017. PMID: 29171364 Free PMC article.
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study.
Nagane M, Ichimura K, Onuki R, Narushima D, Honda-Kitahara M, Satomi K, Tomiyama A, Arai Y, Shibata T, Narita Y, Uzuka T, Nakamura H, Nakada M, Arakawa Y, Ohnishi T, Mukasa A, Tanaka S, Wakabayashi T, Aoki T, Aoki S, Shibui S, Matsutani M, Ishizawa K, Yokoo H, Suzuki H, Morita S, Kato M, Nishikawa R. Nagane M, et al. Among authors: aoki t. Cancers (Basel). 2022 Nov 10;14(22):5522. doi: 10.3390/cancers14225522. Cancers (Basel). 2022. PMID: 36428615 Free PMC article.
A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.
Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y, Ichikawa T, Kobayashi H, Fujimaki T, Goto H, Takeshima H, Ueba T, Abe H, Tamiya T, Sonoda Y, Natsume A, Kakuma T, Sugita Y, Komatsu N, Yamada A, Sasada T, Matsueda S, Shichijo S, Itoh K, Terasaki M. Narita Y, et al. Among authors: aoki t. Neuro Oncol. 2019 Feb 19;21(3):348-359. doi: 10.1093/neuonc/noy200. Neuro Oncol. 2019. PMID: 30500939 Free PMC article. Clinical Trial.
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study.
Aoki T, Kagawa N, Sugiyama K, Wakabayashi T, Arakawa Y, Yamaguchi S, Tanaka S, Ishikawa E, Muragaki Y, Nagane M, Nakada M, Suehiro S, Hata N, Kuroda J, Narita Y, Sonoda Y, Iwadate Y, Natsumeda M, Nakazato Y, Minami H, Hirata Y, Hagihara S, Nishikawa R. Aoki T, et al. Int J Clin Oncol. 2021 Dec;26(12):2205-2215. doi: 10.1007/s10147-021-02028-1. Epub 2021 Sep 29. Int J Clin Oncol. 2021. PMID: 34586548 Free PMC article.
34 results